{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:01:19Z","timestamp":1780290079692,"version":"3.54.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,31]]},"DOI":"10.7759\/cureus.110007","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:19:46Z","timestamp":1780287586000},"source":"Crossref","is-referenced-by-count":0,"title":["Life Course Vaccination Continuum (LCVAC): An Expert Consensus on Life Course Vaccination in India"],"prefix":"10.7759","author":[{"given":"Parvaiz A","family":"Koul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agam","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangesh","family":"Tiwaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. R.","family":"Ramasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Nangia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivekanand","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trayambak","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10111943","article-title":"The vaccine world of COVID-19: India's contribution","volume":"10","author":"Chavda VP","year":"2022","unstructured":"Chavda VP, Vihol DR, Solanki HK, Apostolopoulos V. The vaccine world of COVID-19: India's contribution. Vaccines (Basel). 2022, 10:10.3390\/vaccines10111943","journal-title":"Vaccines (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01526","article-title":"Impact of vaccines; health, economic and social perspectives","volume":"11","author":"Rodrigues CM","year":"2020","unstructured":"Rodrigues CM, Plotkin SA. Impact of vaccines; health, economic and social perspectives. Front Microbiol. 2020, 11:1526. 10.3389\/fmicb.2020.01526","journal-title":"Front Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4557-0090-5.00073-2","article-title":"Regulation and testing of vaccines","author":"Baylor NW","year":"2013","unstructured":"Baylor NW, Marshall VB. Regulation and testing of vaccines. Vaccines. 2013, 1427-46. 10.1016\/B978-1-4557-0090-5.00073-2","journal-title":"Vaccines"},{"key":"ref4","unstructured":"Environmental statistics, accounts and indicators | OECD. (2024). Accessed. May 19, 2026: https:\/\/www.oecd.org\/en\/topics\/environmental-statistics-accounts-and-indicators.html."},{"key":"ref5","unstructured":"Strategic Advisory Group of Experts on Immunization (SAGE). (2024). Accessed. March 19, 2026: https:\/\/www.who.int\/groups\/strategic-advisory-group-of-experts-on-immunization."},{"key":"ref6","article-title":"A brief history of vaccines & vaccination in India","volume":"139","author":"Lahariya C","year":"2014","unstructured":"Lahariya C. A brief history of vaccines & vaccination in India. Indian J Med Res. 2014, 139:491-511.","journal-title":"Indian J Med Res"},{"key":"ref7","article-title":"Public health facility quality and child immunization outcomes in rural India: a decomposition analysis","volume":"6","author":"Summan A","year":"2022","unstructured":"Summan A, Nandi A, Schueller E, Laxminarayan R. Public health facility quality and child immunization outcomes in rural India: a decomposition analysis. Vaccine. 2022, 6:2388-98.","journal-title":"Vaccine"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2021-001060","article-title":"COVID-19-related disruptions to routine vaccination services in India: a survey of paediatric providers","volume":"5","author":"Shet A","year":"2021","unstructured":"Shet A, Dhaliwal B, Banerjee P, et al.. COVID-19-related disruptions to routine vaccination services in India: a survey of paediatric providers. BMJ Paediatr Open. 2021, 5:e001060. 10.1136\/bmjpo-2021-001060","journal-title":"BMJ Paediatr Open"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/lungindia.lungindia_270_20","article-title":"Clinical practice guidelines 2019: Indian consensus-based recommendations on influenza vaccination in adults","volume":"37","author":"Dhar R","year":"2020","unstructured":"Dhar R, Ghoshal AG, Guleria R, et al.. Clinical practice guidelines 2019: Indian consensus-based recommendations on influenza vaccination in adults. Lung India. 2020, 37:S4-S18. 10.4103\/lungindia.lungindia_270_20","journal-title":"Lung India"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4161\/hv.29342","article-title":"Adult immunization in India: importance and recommendations","volume":"11","author":"Verma R","year":"2015","unstructured":"Verma R, Khanna P, Chawla S. Adult immunization in India: importance and recommendations. Hum Vaccin Immunother. 2015, 11:2180-2. 10.4161\/hv.29342","journal-title":"Hum Vaccin Immunother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186903","article-title":"The full benefits of adult pneumococcal vaccination: a systematic review","volume":"12","author":"Cafiero-Fonseca ET","year":"2017","unstructured":"Cafiero-Fonseca ET, Stawasz A, Johnson ST, Sato R, Bloom DE. The full benefits of adult pneumococcal vaccination: a systematic review. PLoS One. 2017, 12:e0186903. 10.1371\/journal.pone.0186903","journal-title":"PLoS One"},{"key":"ref12","article-title":"Guidelines for vaccination in normal adults in India","volume":"26","author":"Singh A","year":"2016","unstructured":"Singh A, Kumar H, Tandon N. Guidelines for vaccination in normal adults in India. Indian J Nephrol. 2016, 26:S7-S14.","journal-title":"Indian J Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/23337214221118237","article-title":"Pneumococcal vaccine recommendations for old-age home Indian residents: a literature review","volume":"8","author":"Ghia CJ","year":"2022","unstructured":"Ghia CJ, Rambhad G. Pneumococcal vaccine recommendations for old-age home Indian residents: a literature review. Gerontol Geriatr Med. 2022, 8:23337214221118237. 10.1177\/23337214221118237","journal-title":"Gerontol Geriatr Med"},{"key":"ref14","article-title":"10, Diphtheria toxoid-, tetanus toxoid-, and acellular pertussis-containing vaccines","author":"Committee to Review Adverse Effects of Vaccines; Institute of Medicine; Stratton K","year":"2011","unstructured":"Committee to Review Adverse Effects of Vaccines; Institute of Medicine; Stratton K, Ford A, Rusch E, et al.. 10, Diphtheria toxoid-, tetanus toxoid-, and acellular pertussis-containing vaccines. Adverse Effects of Vaccines: Evidence and Causality. National Academies Press, Washington, D.C.; 2011. 25:10."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2023.04.402","article-title":"Global epidemiology and burden of tetanus from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"132","author":"Li J","year":"2023","unstructured":"Li J, Liu Z, Yu C, Tan K, Gui S, Zhang S, Shen Y. Global epidemiology and burden of tetanus from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Int J Infect Dis. 2023, 132:118-26. 10.1016\/j.ijid.2023.04.402","journal-title":"Int J Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-18968-y","article-title":"Global burden of pertussis in 204 countries and territories, from 1990 to 2019: results from the Global Burden of Disease Study 2019","volume":"24","author":"Nie Y","year":"2024","unstructured":"Nie Y, Zhang Y, Yang Z, et al.. Global burden of pertussis in 204 countries and territories, from 1990 to 2019: results from the Global Burden of Disease Study 2019. BMC Public Health. 2024, 24:1453. 10.1186\/s12889-024-18968-y","journal-title":"BMC Public Health"},{"key":"ref17","unstructured":"Diphtheria Vaccine Recommendations | Diphtheria | CDC. (2025). Accessed. April 29, 2026: https:\/\/www.cdc.gov\/diphtheria\/hcp\/vaccine-recommendations\/index.html."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.01.045","article-title":"What is the true burden of diphtheria, tetanus, pertussis and poliovirus in children aged 3-18 years in Asia? A systematic literature review","volume":"117","author":"Nicholson L","year":"2022","unstructured":"Nicholson L, Adkins E, Karyanti MR, Ong-Lim A, Shenoy B, Huoi C, Vargas-Zambrano JC. What is the true burden of diphtheria, tetanus, pertussis and poliovirus in children aged 3-18 years in Asia? A systematic literature review. Int J Infect Dis. 2022, 117:116-29. 10.1016\/j.ijid.2022.01.045","journal-title":"Int J Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10050714","article-title":"Influenza viruses and vaccines: the role of vaccine effectiveness studies for evaluation of the benefits of influenza vaccines","volume":"10","author":"Trombetta CM","year":"2022","unstructured":"Trombetta CM, Kistner O, Montomoli E, Viviani S, Marchi S. Influenza viruses and vaccines: the role of vaccine effectiveness studies for evaluation of the benefits of influenza vaccines. Vaccines. 2022, 10:714.","journal-title":"Vaccines"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.36922\/JCTR025060006","article-title":"A systematic review of immunogenicity and safety of influenza subunit vaccines and split vaccines","volume":"11","author":"Wang L","year":"2025","unstructured":"Wang L, Zhang H, Li D, Zhang X, An Y, Chen Z. A systematic review of immunogenicity and safety of influenza subunit vaccines and split vaccines. J Clin Transl Res. 2025, 11:14-37. 10.36922\/JCTR025060006","journal-title":"J Clin Transl Res"},{"key":"ref21","unstructured":"Benefits of the flu vaccine | Flu vaccines work | CDC. (2024). Accessed. October 21, 2024: https:\/\/www.cdc.gov\/flu-vaccines-work\/benefits\/index.html."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmx087","article-title":"Estimation of burden of influenza among under-five children in india: a meta-analysis","volume":"64","author":"Ram Purakayastha D","year":"2018","unstructured":"Ram Purakayastha D, Vishnubhatla S, Rai SK, Broor S, Krishnan A. Estimation of burden of influenza among under-five children in india: a meta-analysis. J Trop Pediatr. 2018, 64:441-53. 10.1093\/tropej\/fmx087","journal-title":"J Trop Pediatr"},{"key":"ref23","unstructured":"Influenza and pneumonia in India | World Life Expectancy. (2020). Accessed. September 23, 2024: https:\/\/www.worldlifeexpectancy.com\/india-influenza-pneumonia."},{"key":"ref24","unstructured":"Update on seasonal influenza. (2023). Accessed. September 23, 2024: https:\/\/www.pib.gov.in\/PressReleasePage.aspx?PRID=1905602&reg=3&lang=2."},{"key":"ref25","article-title":"Life Course Immunization Guidebook: A Quick Reference Guide","author":"Wankhedkar R","year":"2019","unstructured":"Wankhedkar R, Tandon RN, Monga VK, et al.. Life Course Immunization Guidebook: A Quick Reference Guide. Indian Medical Association, New Delhi; 2019."},{"key":"ref26","article-title":"Influenza vaccine","author":"Kalarikkal SM","year":"2026","unstructured":"Kalarikkal SM, Jaishankar GB. Influenza vaccine. StatPearls [Internet]. StatPearls Publishing, Treasure Island; 2026 Jan-."},{"key":"ref27","unstructured":"Seasonal Influenza. Guidelines for Vaccination with Influenza Vaccine | Ministry of Health and Family Welfare, Directorate General of Health Services, National Centre for Disease Control. (2018). Accessed: December 31, 2019: https:\/\/ncdc.mohfw.gov.in\/includes\/Health_Information\/seasonalinfluenza.php."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1533777","article-title":"Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial","volume":"15","author":"Thompson AR","year":"2019","unstructured":"Thompson AR, Klein NP, Downey HJ, et al.. Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial. Hum Vaccin Immunother. 2019, 15:444-51. 10.1080\/21645515.2018.1533777","journal-title":"Hum Vaccin Immunother"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04237-9","article-title":"Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. The","volume":"31","author":"Christenson B","year":"2001","unstructured":"Christenson B, Lundbergh P, Hedlund J, \u00d6rtqvist \u00c5. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. The. Lancet. 2001, 31:1008-11. 10.1016\/S0140-6736(00)04237-9","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(20)30129-2","article-title":"National, regional, and state-level pneumonia and severe pneumonia morbidity in children in India: modelled estimates for 2000 and 2015","volume":"4","author":"Wahl B","year":"2020","unstructured":"Wahl B, Knoll MD, Shet A, et al.. National, regional, and state-level pneumonia and severe pneumonia morbidity in children in India: modelled estimates for 2000 and 2015. Lancet Child Adolesc Health. 2020, 4:678-87. 10.1016\/S2352-4642(20)30129-2","journal-title":"Lancet Child Adolesc Health"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.4103\/0974-777X.193749","article-title":"Consensus recommendation for India and Bangladesh for the use of pneumococcal vaccine in mass gatherings with special reference to Hajj pilgrims","volume":"8","author":"Mathai D","year":"2016","unstructured":"Mathai D, Shamsuzzaman AKM, Feroz AA, et al.. Consensus recommendation for India and Bangladesh for the use of pneumococcal vaccine in mass gatherings with special reference to Hajj pilgrims. J Glob Infect Dis. 2016, 8:129-38.","journal-title":"J Glob Infect Dis"},{"key":"ref32","unstructured":"Pneumococcal disease | World Health Organization. (2019). Accessed. December 31, 2019: https:\/\/www.who.int\/teams\/health-product-policy-and-standards\/standards-and-specifications\/norms-and-standards\/vaccin...."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.4103\/ijoem.IJOEM_50_20","article-title":"Adult immunization in occupational settings: a consensus of Indian experts","volume":"24","author":"Koul PA","year":"2020","unstructured":"Koul PA, Swaminathan S, Rajgopal T, et al.. Adult immunization in occupational settings: a consensus of Indian experts. Indian J Occup Environ Med. 2020, 24:3-15. 10.4103\/ijoem.IJOEM_50_20","journal-title":"Indian J Occup Environ Med"},{"key":"ref34","unstructured":"National Operational Guidelines. Introduction of Pneumococcal Conjugate Vaccine (PCV) | Ministry of Health and Family Welfare, National Centre for Communicable Diseases Mission for Immunisation Strengthening. (2017). Accessed: December 24, 2025: https:\/\/nccmis.mohfw.gov.in\/document\/PCV%20operational%20guidelines.pdf."},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6846a5","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: updated recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Matanock A","year":"2019","unstructured":"Matanock A, Lee G, Gierke R, Kobayashi M, Leidner A, Pilishvili T. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2019, 68:1069-75.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4065\/84.3.274","article-title":"Herpes zoster (shingles) and postherpetic neuralgia","volume":"84","author":"Sampathkumar P","year":"2009","unstructured":"Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc. 2009, 84:274-80. 10.4065\/84.3.274","journal-title":"Mayo Clin Proc"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab121","article-title":"Effectiveness of the recombinant zoster vaccine in adults aged 50 and older in the United States: a claims-based cohort study","volume":"73","author":"Sun Y","year":"2021","unstructured":"Sun Y, Kim E, Kong CL, Arnold BF, Porco TC, Acharya NR. Effectiveness of the recombinant zoster vaccine in adults aged 50 and older in the United States: a claims-based cohort study. Clin Infect Dis. 2021, 73:949-56. 10.1093\/cid\/ciab121","journal-title":"Clin Infect Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2014-051708","article-title":"Population and dyadic-based seroincidence of herpes simplex virus-2 and syphilis in southern India","volume":"91","author":"Hochberg CH","year":"2015","unstructured":"Hochberg CH, Schneider JA, Dandona R, et al.. Population and dyadic-based seroincidence of herpes simplex virus-2 and syphilis in southern India. Sex Transm Infect. 2015, 91:375-82. 10.1136\/sextrans-2014-051708","journal-title":"Sex Transm Infect"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.26719\/2020.26.5.609","article-title":"Seroprevalence of Herpes simplex virus types 1 and 2 in Indian and Filipino migrant populations in Qatar: a cross-sectional survey","volume":"26","author":"Nasrallah G","year":"2020","unstructured":"Nasrallah G, Dargham S, Harfouche M, Abu-Raddad L. Seroprevalence of Herpes simplex virus types 1 and 2 in Indian and Filipino migrant populations in Qatar: a cross-sectional survey. East Mediterr Health J. 2020, 26:609-15. 10.26719\/2020.26.5.609","journal-title":"East Mediterr Health J"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.15879","article-title":"Current shingles vaccine associated with lower risk of dementia","volume":"332","author":"Anderer S","year":"2024","unstructured":"Anderer S. Current shingles vaccine associated with lower risk of dementia. JAMA. 2024, 332:865. 10.1001\/jama.2024.15879","journal-title":"JAMA"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08800-x","article-title":"A natural experiment on the effect of herpes zoster vaccination on dementia","volume":"641","author":"Eyting M","year":"2025","unstructured":"Eyting M, Xie M, Michalik F, He\u00df S, Chung S, Geldsetzer P. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. 2025, 641:438-46. 10.1038\/s41586-025-08800-x","journal-title":"Nature"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1732166","article-title":"Hepatitis B vaccine development and implementation","volume":"16","author":"Zhao H","year":"2020","unstructured":"Zhao H, Zhou X, Zhou YH. Hepatitis B vaccine development and implementation. Hum Vaccin Immunother. 2020, 16:1533-44. 10.1080\/21645515.2020.1732166","journal-title":"Hum Vaccin Immunother"},{"key":"ref43","article-title":"Sero-prevalence of Hepatitis B virus infection among tribal under-five children in aspirational Nabarangpur district of Odisha, India","volume":"1","author":"Sahoo PK","year":"2023","unstructured":"Sahoo PK, Nanda G, Sinha A, Pati S. Sero-prevalence of Hepatitis B virus infection among tribal under-five children in aspirational Nabarangpur district of Odisha, India. Clin Epidemiol Glob Health. 2023, 1:101399.","journal-title":"Clin Epidemiol Glob Health"},{"key":"ref44","unstructured":"National Viral Hepatitis Control Program (NVHCP). (2018). Accessed. September 23, 2024: https:\/\/nhm.hp.gov.in\/nvhcp."},{"key":"ref45","article-title":"119 - Viral Hepatitis","author":"Dienstag JL","year":"2015","unstructured":"Dienstag JL, Delemos AS. 119 - Viral Hepatitis. Bennett\u2019s Principles and Practice of Infectious Diseases (Eighth Edition). Bennett JE, Dolin R, Blaser MJ (ed): W.B. Saunders, Philadelphia; 2015. 1439-68."},{"key":"ref46","article-title":"11 - Routine travel vaccines: hepatitis A and B, typhoid, influenza","author":"Beran J","year":"2013","unstructured":"Beran J, Goad J. 11 - Routine travel vaccines: hepatitis A and B, typhoid, influenza. Travel Medicine (Third Edition). Keystone JS, Freedman DO, Kozarsky PE, Connor BA, Nothdurft HD (ed): Elsevier, London; 2013. 87-100."},{"key":"ref47","unstructured":"Hepatitis A and hepatitis B vaccine. (2024). Accessed. September 23, 2024: https:\/\/www.drugs.com\/mtm\/hepatitis-a-and-hepatitis-b-vaccine.html."},{"key":"ref48","article-title":"Hepatitis A vaccine","author":"Bhandari P","year":"2026","unstructured":"Bhandari P, Brett C, Batool A, et al.. Hepatitis A vaccine. StatPearls [Internet]. StatPearls Publishing, Treasure Island; 2026 Jan-."},{"key":"ref49","unstructured":"Hepatitis B Foundation. Hepatitis B vaccine schedules. (2026). Accessed: September 23, 2024: https:\/\/www.hepb.org\/prevention-and-diagnosis\/vaccination\/guidelines-2\/."},{"key":"ref50","article-title":"Meningococcal Vaccine","author":"Daraghma R","year":"2026","unstructured":"Daraghma R, Sapra A. Meningococcal Vaccine. StatPearls [Internet]. StatPearls Publishing, Treasure Island; 2026."},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-020-00323-4","article-title":"A comprehensive review of meningococcal disease burden in India","volume":"9","author":"Dutta AK","year":"2020","unstructured":"Dutta AK, Swaminathan S, Abitbol V, Kolhapure S, Sathyanarayanan S. A comprehensive review of meningococcal disease burden in India. Infect Dis Ther. 2020, 9:537-59. 10.1007\/s40121-020-00323-4","journal-title":"Infect Dis Ther"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1177\/11786361211053344","article-title":"Meningococcal disease burden in india: a systematic review and meta-analysis","volume":"14","author":"Ghia CJ","year":"2021","unstructured":"Ghia CJ, Rambhad GS. Meningococcal disease burden in india: a systematic review and meta-analysis. Microbiol Insights. 2021, 14:11786361211053344. 10.1177\/11786361211053344","journal-title":"Microbiol Insights"},{"key":"ref53","unstructured":"Meningococcal vaccination. information for health care providers | Vaccines & immunizations | CDC. (2023). Accessed: September 23, 2024: https:\/\/www.cdc.gov\/vaccines\/vpd\/mening\/hcp\/about-vaccine.html."},{"key":"ref54","unstructured":"Centers for Disease Control and Prevention. Meningococcal Vaccine Recommendations. Available at: https:\/\/www.cdc.gov\/meningococcal\/hcp\/vaccine-recommendations\/index.html. Accessed: 30 April 2026.. (2026). https:\/\/www.cdc.gov\/meningococcal\/hcp\/vaccine-recommendations\/index.html."},{"key":"ref55","unstructured":"WHO Immunization Data portal - Detail Page. (2026). Accessed. September 23, 2024: https:\/\/immunizationdata.who.int\/global\/wiise-detail-page."},{"key":"ref56","unstructured":"Meningococcal vaccines - Immunize India. (2016). Accessed. September 23, 2024: https:\/\/immunizeindia.org\/content\/meningococcal-vaccines\/."},{"key":"ref57","doi-asserted-by":"crossref","DOI":"10.1007\/s13312-013-0292-9","article-title":"Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years - India, 2013 and updates on immunization","volume":"50","author":"Vashishtha VM","year":"2013","unstructured":"Vashishtha VM, Kalra A, Bose A, Choudhury P, Yewale VN, Bansal CP, Gupta SG. Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years - India, 2013 and updates on immunization. Indian Pediatr. 2013, 50:1095-108.","journal-title":"Indian Pediatr"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1769389","article-title":"Hepatitis A vaccination","volume":"16","author":"Zhang L","year":"2020","unstructured":"Zhang L. Hepatitis A vaccination. Hum Vaccin Immunother. 2020, 16:1565-73. 10.1080\/21645515.2020.1769389","journal-title":"Hum Vaccin Immunother"},{"key":"ref59","unstructured":"National Viral Hepatitis Control Program Operational Guidelines | Ministry of Health and Family Welfare. (2018). Accessed. December 24, 2025: https:\/\/nvhcp.mohfw.gov.in\/common_libs\/Operational_Guidelines.pdf."},{"key":"ref60","unstructured":"Altered immunocompetence | Vaccines & immunizations | CDC. (2026). Accessed. April 26, 2026: https:\/\/www.cdc.gov\/vaccines\/hcp\/imz-best-practices\/altered-immunocompetence.html."},{"key":"ref61","unstructured":"Haemophilus influenzae type b (Hib) vaccination. information for health care providers | vaccines & immunizations | CDC. (2023). Accessed: September 23, 2024: https:\/\/www.cdc.gov\/vaccines\/vpd\/hib\/hcp\/administering-vaccine.html."},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-021-00864-4","article-title":"Vaccination in older adults: an underutilized opportunity to promote healthy aging in India","volume":"38","author":"Vora A","year":"2021","unstructured":"Vora A, Di Pasquale A, Kolhapure S, Agrawal A. Vaccination in older adults: an underutilized opportunity to promote healthy aging in India. Drugs Aging. 2021, 38:469-79. 10.1007\/s40266-021-00864-4","journal-title":"Drugs Aging"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.59556\/japi.73.0968","article-title":"Establishing Adult Vaccination Clinics in India: A Proposed Framework","volume":"73","author":"Ramasubramanian V","year":"2025","unstructured":"Ramasubramanian V, Kulkarni N, Taur S, Madhumitha R. Establishing Adult Vaccination Clinics in India: A Proposed Framework. J Assoc Physicians India. 2025, 73:21-34. 10.59556\/japi.73.0968","journal-title":"J Assoc Physicians India"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.4103\/lungindia.lungindia_300_18","article-title":"Joint Indian Chest Society-National College of Chest Physicians (India) guidelines for spirometry","volume":"36","author":"Aggarwal AN","year":"2019","unstructured":"Aggarwal AN, Agarwal R, Dhooria S, et al.. Joint Indian Chest Society-National College of Chest Physicians (India) guidelines for spirometry. Lung India. 2019, 36:S1-S35. 10.4103\/lungindia.lungindia_300_18","journal-title":"Lung India"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.29024\/aogh.2302","article-title":"Occupational health in India","volume":"84","author":"Saha RK","year":"2018","unstructured":"Saha RK. Occupational health in India. Ann Glob Health. 2018, 84:330-3. 10.29024\/aogh.2302","journal-title":"Ann Glob Health"},{"key":"ref66","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9060593","article-title":"Lack of trust, conspiracy beliefs, and social media use predict COVID-19 vaccine hesitancy","volume":"9","author":"Jennings W","year":"2021","unstructured":"Jennings W, Stoker G, Bunting H, Valgar\u00f0sson VO, Gaskell J, Devine D. Lack of trust, conspiracy beliefs, and social media use predict COVID-19 vaccine hesitancy. Vaccines. 2021, 9:593.","journal-title":"Vaccines"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.73459","article-title":"Confronting vaccine hesitancy in India: a vital call for unified action","volume":"16","author":"Paul S","year":"2024","unstructured":"Paul S, Salunkhe S, Mane SV, Bahal M. Confronting vaccine hesitancy in India: a vital call for unified action. Cureus. 2024, 16:e73459. 10.7759\/cureus.73459","journal-title":"Cureus"},{"key":"ref68","unstructured":"Who needs a flu vaccine | influenza (flu) | CDC. (2025). Accessed. December 30, 2025: https:\/\/www.cdc.gov\/flu\/vaccines\/vaccinations.html."},{"key":"ref69","unstructured":"Recommended adult immunization schedule 2023 for ages 19 years or older | CDC. (2023). Accessed. February 4, 2024: https:\/\/www.areaagingsolutions.org\/media\/szrasm3h\/final-adult-immunization-schedule-2023.pdf."},{"key":"ref70","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10122103","article-title":"Strategies to increase the percentages of vaccination coverage","volume":"10","author":"Plans-Rubi\u00f3 P","year":"2022","unstructured":"Plans-Rubi\u00f3 P. Strategies to increase the percentages of vaccination coverage. Vaccines. 2022, 10:2103.","journal-title":"Vaccines"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2022.2114900","article-title":"COVID-19 and vaccination: myths vs science","volume":"21","author":"Chavda VP","year":"2022","unstructured":"Chavda VP, Chen Y, Dave J, et al.. COVID-19 and vaccination: myths vs science. Expert Rev Vaccines. 2022, 21:1603-20. 10.1080\/14760584.2022.2114900","journal-title":"Expert Rev Vaccines"},{"key":"ref72","unstructured":"12 COVID-19 Vaccination Strategies for Your Community | CDC. (2022). Accessed. February 4, 2024: https:\/\/archive.cdc.gov\/www_cdc_gov\/vaccines\/covid-19\/vaccinate-with-confidence\/community.html."},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1185878","article-title":"Schools at the center of a public health emergency: leveraging schools for pediatric COVID-19 vaccination","volume":"11","author":"Bode S","year":"2023","unstructured":"Bode S, Irwin MK, Palme' H, Skinner D. Schools at the center of a public health emergency: leveraging schools for pediatric COVID-19 vaccination. Front Public Health. 2023, 11:1185878. 10.3389\/fpubh.2023.1185878","journal-title":"Front Public Health"},{"key":"ref74","unstructured":"Table of contents | Pink book | CDC. (2023). Accessed. February 4, 2024: https:\/\/www.cdc.gov\/pinkbook\/hcp\/table-of-contents\/index.html."},{"key":"ref75","article-title":"Medical 4.0 technologies for healthcare: features, capabilities, and applications","volume":"1","author":"Haleem A","year":"2022","unstructured":"Haleem A, Javaid M, Pratap Singh R, Suman R. Medical 4.0 technologies for healthcare: features, capabilities, and applications. IoT Cyber Phys Sys. 2022, 1:12-30.","journal-title":"IoT Cyber Phys Sys"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2013.301608","article-title":"Six components necessary for effective public health program implementation","volume":"104","author":"Frieden TR","year":"2014","unstructured":"Frieden TR. Six components necessary for effective public health program implementation. Am J Public Health. 2014, 104:17-22. 10.2105\/AJPH.2013.301608","journal-title":"Am J Public Health"},{"key":"ref77","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10071038","article-title":"Access to vaccination among disadvantaged, isolated and difficult-to-reach communities in the WHO European region: a systematic review","volume":"10","author":"Ekezie W","year":"2022","unstructured":"Ekezie W, Awwad S, Krauchenberg A, et al.. Access to vaccination among disadvantaged, isolated and difficult-to-reach communities in the WHO European region: a systematic review. Vaccines. 2022, 10:1038.","journal-title":"Vaccines"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1186\/s12992-023-00987-w","article-title":"Vaccine hesitancy and equity: lessons learned from the past and how they affect the COVID-19 countermeasure in Indonesia","volume":"20","author":"Sinuraya RK","year":"2024","unstructured":"Sinuraya RK, Nuwarda RF, Postma MJ, Suwantika AA. Vaccine hesitancy and equity: lessons learned from the past and how they affect the COVID-19 countermeasure in Indonesia. Global Health. 2024, 20:11. 10.1186\/s12992-023-00987-w","journal-title":"Global Health"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11061022","article-title":"Harnessing the power of collaboration to expand the coverage and equity of COVID-19 vaccinations in india: a community collaboration model","volume":"11","author":"Soni GK","year":"2023","unstructured":"Soni GK, Seth S, Arora S, Singh K, Kumari A, Kanagat N, Fields R. Harnessing the power of collaboration to expand the coverage and equity of COVID-19 vaccinations in india: a community collaboration model. Vaccines (Basel). 2023, 11:10.3390\/vaccines11061022","journal-title":"Vaccines (Basel)"},{"key":"ref80","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2022.100214","article-title":"Critical success factors for high routine immunization performance: a case study of Nepal","volume":"12","author":"Hester KA","year":"2022","unstructured":"Hester KA, Sakas Z, Ellis AS, et al.. Critical success factors for high routine immunization performance: a case study of Nepal. Vaccine X. 2022, 12:100214.","journal-title":"Vaccine X"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/479052-life-course-vaccination-continuum-lcvac-an-expert-consensus-on-life-course-vaccination-in-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:19:52Z","timestamp":1780287592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/479052-life-course-vaccination-continuum-lcvac-an-expert-consensus-on-life-course-vaccination-in-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,31]]},"references-count":80,"URL":"https:\/\/doi.org\/10.7759\/cureus.110007","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,31]]}}}